Q2 2015

Source filing unavailable

Q2 2015 · —

Revenue

$13.22M

+57.2% vs Q2 2014

Net Income

-$31.90M

N/M vs Q2 2014

EPS Diluted

-$0.85

N/M vs Q2 2014

Operating Income-$32,133,000N/M

Operating Cash Flowderived$3,980,000N/M

Same quarter

Metric	Q2 2015	Q2 2014	Q2 2013	Q2 2012
Revenue	$13.22M	$8.41M	$6.27M	$6.29M
Net Income	-$31.90M	-$18.30M	-$8.62M	-$5.51M
EPS Diluted	-$0.85	-$0.54	-$2.80	-$2.18

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Agios Pharmaceuticals, Inc. · CIK 1439222 · Engraved from SEC EDGAR